Methadone/Buprenorphine Cross-Over Study - 4
NCT00000208 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-08-17
Summary
The purpose of this study is to explore ways to cross patients over from methadone to buprenorphine.
Conditions
- Opioid-Related Disorders
Interventions
- DRUG
-
Buprenorphine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Walter Ling, M.D. · Friends Research Institute, Inc.
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-02-29
Countries
- United States
Study Locations
More Related Trials
-
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Clinical Trial of Buprenorphine - 3
NCT00000207 ·Status: COMPLETED ·Phase: PHASE3
-
Alternate-Day Buprenorphine Administration. Phase VIII - 9
NCT00000227 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
NCT01359930 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine
NCT06628622 ·Status: SUSPENDED ·Phase: PHASE1
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000222 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
NCT01642030 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000223 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
NCT00000329 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase I - 3
NCT00000221 ·Status: COMPLETED ·Phase: PHASE1
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015
NCT01125917 ·Status: TERMINATED ·Phase: PHASE3
-
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT00490919 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2